Research advances in the identification of clinical biomarkers for liver diseases using metabolomics based on ultra-performance liquid chromatography-mass spectrometry
10.3969/j.issn.1001-5256.2017.05.040
- VernacularTitle:基于超高效液相色谱-质谱的代谢组学在肝脏疾病生物标志物发现中的作用
- Author:
Xuan ZHOU
;
Yong LAI
- Keywords:
liver diseases;
metabonomics;
biological markers;
ultra-performance liquid chromatography-mass spectrometry;
review
- From:
Journal of Clinical Hepatology
2017;33(5):979-984
- CountryChina
- Language:Chinese
-
Abstract:
The biomarkers currently known for the early diagnosis of liver diseases often have poor sensitivities and specificities,and thus it is very important to find new biomarkers with high sensitivities and specificities for the early diagnosis of liver diseases.The emerging metabolomics technology has been widely used and may help to achieve this goal.This article reviewsthe research advances in the role of metabolomics based on ultra-performance liquid chromatography-mass spectrometry in the identification of biomarkers for liver diseases and emphasizes its significance in the early diagnosis,treatment,and prognosis evaluation of liver diseases.
